![MyCancerHaven for Healthcare Professionals](/img/default-banner.jpg)
- Видео 27
- Просмотров 1 131
MyCancerHaven for Healthcare Professionals
США
Добавлен 8 фев 2024
My_Cancer_Haven provide a custom designed, curated and moderated, cloud based platform for cancer patients, and cancer focused experts, researchers and organizations to create cancer-type specific ecosystems to enable dissemination of information, educational and research initiatives, aiming to reduce disparity in cancer care and also offer tools for patients to form communities with their peers and a sanctuary with family and friends.
Ravi Vij, in Discussion with Dr. Joshua Zeidner MD, On Asciminib for Treating CML
Ravi Vij, in Discussion with Dr. Joshua Zeidner MD, Associate Professor of Medicine Cheif, Leukemia Research, Director Clinical Cancer Research Commercial Integration. Division of Hematology, UNC School of Medicine: On Asciminib for treating CML
Просмотров: 8
Видео
Ravi Vij, in Discussion with Dr. Nicholas Short MD on Incorporating Blincyto and Besponsa in ALL
Просмотров 1319 часов назад
Ravi Vij, in Discussion with Dr. Nicholas Short MD, Associate Professor, Department of Leukemia, University of Texas MD Andersen Cancer Center, Houston, Texas, on: Incorporating Blincyto and Besponsa in ALL
Ravi Vij, in Discussion with Dr. Danielle M Brander MD, on Evolving Concepts in CLL Management: MRD
Просмотров 1214 дней назад
Ravi Vij, in Discussion with Dr. Danielle M Brander MD, Associate Professor of Medicine, Director of CLL & Lymphoma Research, Duke Cancer Institute, on Evolving Concepts in CLL Management: MRD
Ravi Vij, in Discussion with Dr. Forat Lutfi MD, Assistant Professor, on Lisocel for DLBCL and MCL
Просмотров 1821 день назад
Ravi Vij, in Discussion with Dr. Forat Lutfi MD, Assistant Professor, Hematologic Malignancies and Cellular Therapeutics, Kansan University Medical Center, on Lisocel for DLBCL and MCL
Ravi Vij, in Discussion with Dr. Adriana Rossi MD, on ISATUXIMAB for Transplant Ineligible Patients
Просмотров 2828 дней назад
Ravi Vij, in Discussion with Dr. Adriana Rossi MD, Assistant Professor, Director CAR-T & Stem Cell Transplant Clinical Program, Mt. Sinai Hospital, New York, on ISATUXIMAB: For Front-line Transplant Ineligible Patients. IMROZ and BENEFIT Studies
Ravi Vij, in Discussion with Dr. Guru Subramanian Guru Murthy MD MS: on BPDCN
Просмотров 35Месяц назад
Ravi Vij, in Discussion with Dr. Guru Subramanian Guru Murthy MD MS: on BPDCN Blastic Plasmacytoid Dendritic Cell Neoplasm
Multiple Myeloma: Ready for the Return of Belantamab Mafadotin?
Просмотров 17Месяц назад
Ravi Vij, in Discussion with Dr. Ajai Chari MD, on Multiple Myeloma: Ready for the Return of Belantamab Mafadotin?
Ravi Vij, in Discussion with Dr. Nirav Shah MD, on CAR-T Cells for Chronic Lymphocytic Leukemia
Просмотров 29Месяц назад
Ravi Vij, in Discussion with Dr. Nirav Shah MD, Hematology, Medical Oncology, Medical College of Wisconsin, Milwaukea, WI: On CAR-T Cells for Chronic Lymphocytic Leukemia
Ravi Vij, in Discussion with Dr. Sascha Alexander Tuchman, MD On Managing M-Myeloma In The Elderly
Просмотров 402 месяца назад
Ravi Vij, in Discussion with Dr. Sascha Alexander Tuchman, MD, MS, Professor of Medicine, Director, Multiple Myeloma & Amyloidosis Program, UNC School of Medicine: On Managing Multiple Myeloma In The Elderly. Transcript
Ravi Vij in Discussion With Dr. Jesus Gonzalez Lugo, MD, on MDS: How He Intend to Use Imetelstat
Просмотров 5042 месяца назад
Ravi Vij in Discussion With Dr. Jesus Gonzalez Lugo, MD, Assistant Professor, Hematologic Malignacies & Cellular Therapeutics, Kansas University Medical Center: On MDS: How He Intend to Use Imetelstat in His Practice
Ravi Vij in Discussion with Dr. Nitya Nathwani MD on Choosing Between CAR-Ts & Bispecific Antibodies
Просмотров 542 месяца назад
Ravi Vij in Discussion with Dr. Nitya Nathwani MD, Assistant Profesor, Division of Myeloma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte. CA: on Multiple Myeloma: How I Choose Between CAR-Ts and Bispecific Antibodies
Will CAR-Ts & Bispecifics elminate HSCT for Multiple Myeloma? Dr. Samer Al Hadidi MD with Ravi Vij
Просмотров 212 месяца назад
Ravi Vij in Discussion with Dr. Samer Al Hadidi MD,MS,FACP, Assistant Profesor of Medicine, University of Arkansas for Medical Sciences AR, on: Will CAR-Ts & Bispecifics elminate HSCT for Multiple Myeloma?
Will CAR-Ts & Bispecifics elminate HSCT for Multiple Myeloma? Ravi Vij with Dr. Samer Al Hadidi MD
Просмотров 192 месяца назад
Ravi Vij in Discussion with Dr. Samer Al Hadidi MD,MS,FACP, Assitant Profesor of Medicine on: Will CAR-Ts & Bispecifics elminate HSCT for Multiple Myeloma?
Ravi Vij in Discussion with Dr. Sanghee Hong, MD, on How She Decides on HSCT
Просмотров 132 месяца назад
Ravi Vij in Discussion with Dr. Sanghee Hong, MD, Assitant Profesor of Medicine, Duke Cance Institute: on How She Decides on HSCT - Hematopoietic Stem Cell Transplantation
Ravi Vij in Discussion with Dr. Al-Ola A Abdallah, MD on Using CAR-T Cells Post 1st Relapse in MM
Просмотров 353 месяца назад
Ravi Vij in Discussion with Dr. Al-Ola A Abdallah, MD on Using CAR-T Cells Post 1st Relapse in MM
Ravi Vij in Discussion with Dr. Suzanne Lentzsch MD, PhD on Novel Monoclonal Antibodies
Просмотров 153 месяца назад
Ravi Vij in Discussion with Dr. Suzanne Lentzsch MD, PhD on Novel Monoclonal Antibodies
Ravi Vij in Discussion with Dr. Tom Martin MD, on How the Pegasus & Iskia Trial Influenced
Просмотров 183 месяца назад
Ravi Vij in Discussion with Dr. Tom Martin MD, on How the Pegasus & Iskia Trial Influenced
Ravi Vij, in Discussion with Dr. Cristina Gasparetto, MD on Using Selinexor in the Practice
Просмотров 773 месяца назад
Ravi Vij, in Discussion with Dr. Cristina Gasparetto, MD on Using Selinexor in the Practice
Ravi Vij in Discussion with Dr. Nathan Singh MD, MS on CAR-T Cell Therapy: Where are we Headed?
Просмотров 124 месяца назад
Ravi Vij in Discussion with Dr. Nathan Singh MD, MS on CAR-T Cell Therapy: Where are we Headed?
Ravi Vij in Discussion with Dr. Jeffrey Zondor MD, on Treating Amyloidosis at @MCH
Просмотров 164 месяца назад
Ravi Vij in Discussion with Dr. Jeffrey Zondor MD, on Treating Amyloidosis at @MCH
Ravi Vij in Discussion with Dr. Stephen Oh, MD, Co-Chief Division of Hematology on Myelofibrosis
Просмотров 285 месяцев назад
Ravi Vij in Discussion with Dr. Stephen Oh, MD, Co-Chief Division of Hematology on Myelofibrosis
Ravi Vij in Discussion with Dr. Muzaffar Qazilbash MD, On Role of Stem Cell Transplantation in AML
Просмотров 205 месяцев назад
Ravi Vij in Discussion with Dr. Muzaffar Qazilbash MD, On Role of Stem Cell Transplantation in AML
Ravi Vij in Discussion with Dr. Jorge Castillo MD, on Waldenstrom Macroglobinemia
Просмотров 375 месяцев назад
Ravi Vij in Discussion with Dr. Jorge Castillo MD, on Waldenstrom Macroglobinemia
Ravi Vij in discussion with Dr. Nelson Leung on Myeloma & The Kidneys
Просмотров 245 месяцев назад
Ravi Vij in discussion with Dr. Nelson Leung on Myeloma & The Kidneys
Ravi Vij in discussion with Dr. Mikkael Sekeres on Recent Advances in Myelodysplastic Syndromes
Просмотров 266 месяцев назад
Ravi Vij in discussion with Dr. Mikkael Sekeres on Recent Advances in Myelodysplastic Syndromes
Ravi Vij in discussion with Dr Brad Kahl, Professor of Medicine Washington University
Просмотров 166 месяцев назад
Ravi Vij in discussion with Dr Brad Kahl, Professor of Medicine Washington University